Integrum says OPRA implant study in Ukrainian war veterans shows 97.9% survival at 1 year after S2
Integrum flagged a newly published clinical study on its OPRA implant system in Ukrainian war veterans with combat-related amputations. Results were presented as published findings, not a future conference readout. Study outcomes pointed to strong short-term implant durability with no mechanical failures reported, desp